ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Split Influenza Vaccine Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-35R14310
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Split Influenza Vaccine Market Research Report 2023
BUY CHAPTERS

Global Split Influenza Vaccine Market Research Report 2025

Code: QYRE-Auto-35R14310
Report
May 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi Pasteur
GSK
Seqirus
StraZeneca Plc
Dalian Yali Peak
CSL Seqirus

Split Influenza Vaccine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Split Influenza Vaccine Market

Split Influenza Vaccine Market

The global market for Split Influenza Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Influenza virus split vaccine is made by inoculating chicken embryos with influenza virus strains recommended by the World Health Organization (WHO) and approved by the national drug administration department, cultured, harvested virus liquid, virus inactivated, purified, and cracked. For the prevention of influenza caused by this type of virus.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Split Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Split Influenza Vaccine.
The Split Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Split Influenza Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Split Influenza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Split Influenza Vaccine Market Report

Report Metric Details
Report Name Split Influenza Vaccine Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi Pasteur, CSL Seqirus, GSK, Seqirus, Inc., straZeneca, Dalian Yali Peak
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Split Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Split Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Split Influenza Vaccine Market report?

Ans: The main players in the Split Influenza Vaccine Market are Sanofi Pasteur, CSL Seqirus, GSK, Seqirus, Inc., straZeneca, Dalian Yali Peak

What are the Application segmentation covered in the Split Influenza Vaccine Market report?

Ans: The Applications covered in the Split Influenza Vaccine Market report are Hospital, Clinic

What are the Type segmentation covered in the Split Influenza Vaccine Market report?

Ans: The Types covered in the Split Influenza Vaccine Market report are Aldult, Child

Recommended Reports

Influenza Vaccine Markets

General Vaccine Technologies

Vaccine Storage & Diagnostics

1 Split Influenza Vaccine Market Overview
1.1 Product Definition
1.2 Split Influenza Vaccine by Type
1.2.1 Global Split Influenza Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Aldult
1.2.3 Child
1.3 Split Influenza Vaccine by Application
1.3.1 Global Split Influenza Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Split Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Split Influenza Vaccine Revenue 2020-2031
1.4.2 Global Split Influenza Vaccine Sales 2020-2031
1.4.3 Global Split Influenza Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Split Influenza Vaccine Market Competition by Manufacturers
2.1 Global Split Influenza Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Split Influenza Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Split Influenza Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Split Influenza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Split Influenza Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Split Influenza Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Split Influenza Vaccine, Date of Enter into This Industry
2.8 Global Split Influenza Vaccine Market Competitive Situation and Trends
2.8.1 Global Split Influenza Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Split Influenza Vaccine Players Market Share by Revenue
2.8.3 Global Split Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Split Influenza Vaccine Market Scenario by Region
3.1 Global Split Influenza Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Split Influenza Vaccine Sales by Region: 2020-2031
3.2.1 Global Split Influenza Vaccine Sales by Region: 2020-2025
3.2.2 Global Split Influenza Vaccine Sales by Region: 2026-2031
3.3 Global Split Influenza Vaccine Revenue by Region: 2020-2031
3.3.1 Global Split Influenza Vaccine Revenue by Region: 2020-2025
3.3.2 Global Split Influenza Vaccine Revenue by Region: 2026-2031
3.4 North America Split Influenza Vaccine Market Facts & Figures by Country
3.4.1 North America Split Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Split Influenza Vaccine Sales by Country (2020-2031)
3.4.3 North America Split Influenza Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Split Influenza Vaccine Market Facts & Figures by Country
3.5.1 Europe Split Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Split Influenza Vaccine Sales by Country (2020-2031)
3.5.3 Europe Split Influenza Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Split Influenza Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Split Influenza Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Split Influenza Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Split Influenza Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Split Influenza Vaccine Market Facts & Figures by Country
3.7.1 Latin America Split Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Split Influenza Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Split Influenza Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Split Influenza Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Split Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Split Influenza Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Split Influenza Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Split Influenza Vaccine Sales by Type (2020-2031)
4.1.1 Global Split Influenza Vaccine Sales by Type (2020-2025)
4.1.2 Global Split Influenza Vaccine Sales by Type (2026-2031)
4.1.3 Global Split Influenza Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Split Influenza Vaccine Revenue by Type (2020-2031)
4.2.1 Global Split Influenza Vaccine Revenue by Type (2020-2025)
4.2.2 Global Split Influenza Vaccine Revenue by Type (2026-2031)
4.2.3 Global Split Influenza Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Split Influenza Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Split Influenza Vaccine Sales by Application (2020-2031)
5.1.1 Global Split Influenza Vaccine Sales by Application (2020-2025)
5.1.2 Global Split Influenza Vaccine Sales by Application (2026-2031)
5.1.3 Global Split Influenza Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Split Influenza Vaccine Revenue by Application (2020-2031)
5.2.1 Global Split Influenza Vaccine Revenue by Application (2020-2025)
5.2.2 Global Split Influenza Vaccine Revenue by Application (2026-2031)
5.2.3 Global Split Influenza Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Split Influenza Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Company Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Split Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Pasteur Split Influenza Vaccine Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 CSL Seqirus
6.2.1 CSL Seqirus Company Information
6.2.2 CSL Seqirus Description and Business Overview
6.2.3 CSL Seqirus Split Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Seqirus Split Influenza Vaccine Product Portfolio
6.2.5 CSL Seqirus Recent Developments/Updates
6.3 GSK
6.3.1 GSK Company Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Split Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GSK Split Influenza Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Seqirus, Inc.
6.4.1 Seqirus, Inc. Company Information
6.4.2 Seqirus, Inc. Description and Business Overview
6.4.3 Seqirus, Inc. Split Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Seqirus, Inc. Split Influenza Vaccine Product Portfolio
6.4.5 Seqirus, Inc. Recent Developments/Updates
6.5 straZeneca
6.5.1 straZeneca Company Information
6.5.2 straZeneca Description and Business Overview
6.5.3 straZeneca Split Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 straZeneca Split Influenza Vaccine Product Portfolio
6.5.5 straZeneca Recent Developments/Updates
6.6 Dalian Yali Peak
6.6.1 Dalian Yali Peak Company Information
6.6.2 Dalian Yali Peak Description and Business Overview
6.6.3 Dalian Yali Peak Split Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Dalian Yali Peak Split Influenza Vaccine Product Portfolio
6.6.5 Dalian Yali Peak Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Split Influenza Vaccine Industry Chain Analysis
7.2 Split Influenza Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Split Influenza Vaccine Production Mode & Process Analysis
7.4 Split Influenza Vaccine Sales and Marketing
7.4.1 Split Influenza Vaccine Sales Channels
7.4.2 Split Influenza Vaccine Distributors
7.5 Split Influenza Vaccine Customer Analysis
8 Split Influenza Vaccine Market Dynamics
8.1 Split Influenza Vaccine Industry Trends
8.2 Split Influenza Vaccine Market Drivers
8.3 Split Influenza Vaccine Market Challenges
8.4 Split Influenza Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi Pasteur
GSK
Seqirus
StraZeneca Plc
Dalian Yali Peak
CSL Seqirus
List of Tables
 Table 1. Global Split Influenza Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Split Influenza Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Split Influenza Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Split Influenza Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Split Influenza Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Split Influenza Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Split Influenza Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Split Influenza Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Split Influenza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Split Influenza Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Split Influenza Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Split Influenza Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Split Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Split Influenza Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Split Influenza Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Split Influenza Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Split Influenza Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Split Influenza Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Split Influenza Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Split Influenza Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Split Influenza Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Split Influenza Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Split Influenza Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Split Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Split Influenza Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Split Influenza Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Split Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Split Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Split Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Split Influenza Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Split Influenza Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Split Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Split Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Split Influenza Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Split Influenza Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Split Influenza Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Split Influenza Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Split Influenza Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Split Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Split Influenza Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Split Influenza Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Split Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Split Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Split Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Split Influenza Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Split Influenza Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Split Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Split Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Split Influenza Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Split Influenza Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Split Influenza Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Split Influenza Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Split Influenza Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Split Influenza Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Split Influenza Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Split Influenza Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Split Influenza Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Split Influenza Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Split Influenza Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Split Influenza Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Split Influenza Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Split Influenza Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Split Influenza Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Split Influenza Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Split Influenza Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Split Influenza Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Split Influenza Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Split Influenza Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Sanofi Pasteur Company Information
 Table 71. Sanofi Pasteur Description and Business Overview
 Table 72. Sanofi Pasteur Split Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sanofi Pasteur Split Influenza Vaccine Product
 Table 74. Sanofi Pasteur Recent Developments/Updates
 Table 75. CSL Seqirus Company Information
 Table 76. CSL Seqirus Description and Business Overview
 Table 77. CSL Seqirus Split Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. CSL Seqirus Split Influenza Vaccine Product
 Table 79. CSL Seqirus Recent Developments/Updates
 Table 80. GSK Company Information
 Table 81. GSK Description and Business Overview
 Table 82. GSK Split Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. GSK Split Influenza Vaccine Product
 Table 84. GSK Recent Developments/Updates
 Table 85. Seqirus, Inc. Company Information
 Table 86. Seqirus, Inc. Description and Business Overview
 Table 87. Seqirus, Inc. Split Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Seqirus, Inc. Split Influenza Vaccine Product
 Table 89. Seqirus, Inc. Recent Developments/Updates
 Table 90. straZeneca Company Information
 Table 91. straZeneca Description and Business Overview
 Table 92. straZeneca Split Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. straZeneca Split Influenza Vaccine Product
 Table 94. straZeneca Recent Developments/Updates
 Table 95. Dalian Yali Peak Company Information
 Table 96. Dalian Yali Peak Description and Business Overview
 Table 97. Dalian Yali Peak Split Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Dalian Yali Peak Split Influenza Vaccine Product
 Table 99. Dalian Yali Peak Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Split Influenza Vaccine Distributors List
 Table 103. Split Influenza Vaccine Customers List
 Table 104. Split Influenza Vaccine Market Trends
 Table 105. Split Influenza Vaccine Market Drivers
 Table 106. Split Influenza Vaccine Market Challenges
 Table 107. Split Influenza Vaccine Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Split Influenza Vaccine
 Figure 2. Global Split Influenza Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Split Influenza Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Aldult Product Picture
 Figure 5. Child Product Picture
 Figure 6. Global Split Influenza Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Split Influenza Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Global Split Influenza Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Split Influenza Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Split Influenza Vaccine Sales (2020-2031) & (K Units)
 Figure 13. Global Split Influenza Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 14. Split Influenza Vaccine Report Years Considered
 Figure 15. Split Influenza Vaccine Sales Share by Manufacturers in 2024
 Figure 16. Global Split Influenza Vaccine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Split Influenza Vaccine Players: Market Share by Revenue in Split Influenza Vaccine in 2024
 Figure 18. Split Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Split Influenza Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Split Influenza Vaccine Sales Market Share by Country (2020-2031)
 Figure 21. North America Split Influenza Vaccine Revenue Market Share by Country (2020-2031)
 Figure 22. United States Split Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Split Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Split Influenza Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Split Influenza Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Split Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Split Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Split Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Split Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Split Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Split Influenza Vaccine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Split Influenza Vaccine Revenue Market Share by Region (2020-2031)
 Figure 33. China Split Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Split Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Split Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Split Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Split Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Split Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Split Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Split Influenza Vaccine Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Split Influenza Vaccine Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Split Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Split Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Split Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Split Influenza Vaccine Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Split Influenza Vaccine Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Split Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Split Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Split Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Split Influenza Vaccine by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Split Influenza Vaccine by Type (2020-2031)
 Figure 52. Global Split Influenza Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Split Influenza Vaccine by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Split Influenza Vaccine by Application (2020-2031)
 Figure 55. Global Split Influenza Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 56. Split Influenza Vaccine Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Tetravalent Influenza Virus Lysate Vaccine Market Research Report 2024
Influenza Virus Vaccine H1N1 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Animal Flu Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Influenza Vaccine Split Virion Inactivated Quadrivalent Market Research Report 2024
Influenza Virus Vector Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poultry Viral Disease Vaccines Market Research Report 2024
General Influenza Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA Flu Vaccine Market Research Report 2024
Global Influenza Virus Kits Market Research Report 2024
Influenza Daignostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cell based Flu Vaccine Market
VLP Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inactivated Influenza Virus Vaccine Market Research Report 2025
Global Genetically Engineered Vaccines for Poultry Market Research Report 2024
Global Trivalent Split Influenza Vaccine Market Research Report 2025
Live and Attenuated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Commercial Fish Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poultry Liquid Vaccine Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions